Matthew Scott Harris, Chief Medical Officer at Altimmune, Inc. (ALT), sold 30,000 shares at $7.52 ($226K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Open-market sale of $226k ALT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |